<li>abobotulinumtoxina<p>lithium increases effects of abobotulinumtoxina by unknown mechanism. Minor/Significance Unknown.</p></li><li>alprazolam<p>alprazolam increases levels of lithium by decreasing renal clearance. Minor/Significance Unknown.</p></li><li>amitriptyline<p>lithium, amitriptyline. Other (see comment). Minor/Significance Unknown. 
Comment: Risk of neurotoxicity in geriatric pts.  Multiple mechanisms involved.</p></li><li>amlodipine<p>amlodipine increases toxicity of lithium by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of neurotoxicity.</p></li><li>amoxapine<p>lithium, amoxapine. Other (see comment). Minor/Significance Unknown. 
Comment: Risk of neurotoxicity in geriatric pts.  Multiple mechanisms involved.</p></li><li>atracurium<p>lithium increases effects of atracurium by unknown mechanism. Minor/Significance Unknown.</p></li><li>cadexomer iodine<p>cadexomer iodine, lithium. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Additive hypothyroid effects.</p></li><li>cisatracurium<p>lithium increases effects of cisatracurium by unknown mechanism. Minor/Significance Unknown.</p></li><li>clevidipine<p>clevidipine increases toxicity of lithium by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of neurotoxicity.</p></li><li>clomipramine<p>lithium, clomipramine. Other (see comment). Minor/Significance Unknown. 
Comment: Risk of neurotoxicity in geriatric pts.  Multiple mechanisms involved.</p></li><li>desipramine<p>lithium, desipramine. Other (see comment). Minor/Significance Unknown. 
Comment: Risk of neurotoxicity in geriatric pts.  Multiple mechanisms involved.</p></li><li>diltiazem<p>diltiazem increases toxicity of lithium by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of neurotoxicity.</p></li><li>dosulepin<p>lithium, dosulepin. Other (see comment). Minor/Significance Unknown. 
Comment: Risk of neurotoxicity in geriatric pts.  Multiple mechanisms involved.</p></li><li>doxepin<p>lithium, doxepin. Other (see comment). Minor/Significance Unknown. 
Comment: Risk of neurotoxicity in geriatric pts.  Multiple mechanisms involved.</p></li><li>duloxetine<p>duloxetine, lithium. Mechanism: unknown. Minor/Significance Unknown. Risk of neurotoxicity.</p></li><li>dyphylline<p>dyphylline decreases levels of lithium by increasing renal clearance. Minor/Significance Unknown.</p></li><li>escitalopram<p>escitalopram, lithium. Mechanism: unknown. Minor/Significance Unknown. Risk of neurotoxicity.</p></li><li>ethotoin<p>ethotoin increases toxicity of lithium by unknown mechanism. Minor/Significance Unknown.</p></li><li>felodipine<p>felodipine increases toxicity of lithium by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of neurotoxicity.</p></li><li>fluoxetine<p>fluoxetine, lithium. Mechanism: unknown. Minor/Significance Unknown. Risk of neurotoxicity.</p></li><li>fluvoxamine<p>fluvoxamine, lithium. Mechanism: unknown. Minor/Significance Unknown. Risk of neurotoxicity.</p></li><li>fosphenytoin<p>fosphenytoin increases toxicity of lithium by unknown mechanism. Minor/Significance Unknown.</p></li><li>green tea<p>green tea increases levels of lithium by unspecified interaction mechanism. Minor/Significance Unknown. Lithium levels may increase following abrupt caffeine withdrawal.</p></li><li>imipramine<p>lithium, imipramine. Other (see comment). Minor/Significance Unknown. 
Comment: Risk of neurotoxicity in geriatric pts.  Multiple mechanisms involved.</p></li><li>incobotulinumtoxina<p>lithium increases effects of incobotulinumtoxina by unknown mechanism. Minor/Significance Unknown.</p></li><li>iodinated glycerol<p>iodinated glycerol, lithium. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Additive hypothyroid effects.</p></li><li>iodine<p>iodine, lithium. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Additive hypothyroid effects.</p></li><li>isradipine<p>isradipine increases toxicity of lithium by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of neurotoxicity.</p></li><li>lacidipine<p>lacidipine increases toxicity of lithium by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of neurotoxicity.</p></li><li>lercanidipine<p>lercanidipine increases toxicity of lithium by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of neurotoxicity.</p></li><li>levomilnacipran<p>levomilnacipran, lithium. Mechanism: unknown. Minor/Significance Unknown. Risk of neurotoxicity.</p></li><li>lofepramine<p>lithium, lofepramine. Other (see comment). Minor/Significance Unknown. 
Comment: Risk of neurotoxicity in geriatric pts.  Multiple mechanisms involved.</p></li><li>maprotiline<p>lithium, maprotiline. Other (see comment). Minor/Significance Unknown. 
Comment: Risk of neurotoxicity in geriatric pts.  Multiple mechanisms involved.</p></li><li>methyldopa<p>methyldopa increases toxicity of lithium by unknown mechanism. Minor/Significance Unknown.</p></li><li>metronidazole<p>metronidazole increases levels of lithium by decreasing metabolism. Minor/Significance Unknown.</p></li><li>mianserin<p>lithium, mianserin. Other (see comment). Minor/Significance Unknown. 
Comment: Risk of neurotoxicity in geriatric pts.  Multiple mechanisms involved.</p></li><li>milnacipran<p>milnacipran, lithium. Mechanism: unknown. Minor/Significance Unknown. Risk of neurotoxicity.</p></li><li>nefazodone<p>nefazodone, lithium. Mechanism: unknown. Minor/Significance Unknown. Risk of neurotoxicity.</p></li><li>nicardipine<p>nicardipine increases toxicity of lithium by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of neurotoxicity.</p></li><li>nifedipine<p>nifedipine increases toxicity of lithium by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of neurotoxicity.</p></li><li>nisoldipine<p>nisoldipine increases toxicity of lithium by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of neurotoxicity.</p></li><li>nortriptyline<p>lithium, nortriptyline. Other (see comment). Minor/Significance Unknown. 
Comment: Risk of neurotoxicity in geriatric pts.  Multiple mechanisms involved.</p></li><li>onabotulinumtoxina<p>lithium increases effects of onabotulinumtoxina by unknown mechanism. Minor/Significance Unknown.</p></li><li>pancuronium<p>lithium increases effects of pancuronium by unknown mechanism. Minor/Significance Unknown.</p></li><li>paroxetine<p>paroxetine, lithium. Mechanism: unknown. Minor/Significance Unknown. Risk of neurotoxicity.</p></li><li>phenytoin<p>phenytoin increases toxicity of lithium by unknown mechanism. Minor/Significance Unknown.</p></li><li>potassium iodide<p>potassium iodide, lithium. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Additive hypothyroid effects.</p></li><li>protriptyline<p>lithium, protriptyline. Other (see comment). Minor/Significance Unknown. 
Comment: Risk of neurotoxicity in geriatric pts.  Multiple mechanisms involved.</p></li><li>rapacuronium<p>lithium increases effects of rapacuronium by unknown mechanism. Minor/Significance Unknown.</p></li><li>rimabotulinumtoxinb<p>lithium increases effects of rimabotulinumtoxinb by unknown mechanism. Minor/Significance Unknown.</p></li><li>rocuronium<p>lithium increases effects of rocuronium by unknown mechanism. Minor/Significance Unknown.</p></li><li>sargramostim<p>lithium increases effects of sargramostim by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>sertraline<p>sertraline, lithium. Mechanism: unknown. Minor/Significance Unknown. Risk of neurotoxicity.</p></li><li>sodium chloride<p>sodium chloride, lithium. Other (see comment). Minor/Significance Unknown. 
Comment: High sodium intake decreases lithium concentration; low sodium may increase lithium levels.  Mechanism:  Lithium excretion is proportional to salt intake.</p></li><li>sodium polystyrene sulfonate<p>sodium polystyrene sulfonate decreases levels of lithium by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.</p></li><li>succinylcholine<p>lithium increases effects of succinylcholine by unknown mechanism. Minor/Significance Unknown.</p></li><li>theophylline<p>theophylline decreases levels of lithium by increasing renal clearance. Minor/Significance Unknown.</p></li><li>trazodone<p>lithium, trazodone. Other (see comment). Minor/Significance Unknown. 
Comment: Risk of neurotoxicity in geriatric pts.  Multiple mechanisms involved.<span><br><br></span>trazodone, lithium. Mechanism: unknown. Minor/Significance Unknown. Risk of neurotoxicity.</p></li><li>trimipramine<p>lithium, trimipramine. Other (see comment). Minor/Significance Unknown. 
Comment: Risk of neurotoxicity in geriatric pts.  Multiple mechanisms involved.</p></li><li>tubocurarine<p>lithium increases effects of tubocurarine by unknown mechanism. Minor/Significance Unknown.</p></li><li>vasopressin<p>lithium decreases effects of vasopressin by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>vecuronium<p>lithium increases effects of vecuronium by unknown mechanism. Minor/Significance Unknown.</p></li><li>venlafaxine<p>venlafaxine, lithium. Mechanism: unknown. Minor/Significance Unknown. Risk of neurotoxicity.</p></li><li>verapamil<p>verapamil increases toxicity of lithium by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of neurotoxicity.</p></li>